Ahpra registration PHY0002298174
How these guides are written and reviewed →
A Rapihaler is a pressurised puffer (pMDI) with a dose counter, used with the standard slow press-and-breathe technique. It can be used with a spacer, which most people find easier.
Symbicort Rapihaler (budesonide / formoterol) is unusual: for some people it is prescribed as a preventer only, and for others as both preventer and reliever (maintenance-and-reliever therapy, or MART). The two regimens are not interchangeable, and taking extra doses is only safe if MART has been prescribed for you. Your written action plan states which applies — if it does not, ask before taking an extra dose.
Examples of this type
Different medicines come in this device. Common examples include:
- Symbicort Rapihaler (budesonide / formoterol)
Brand names are examples only and availability changes — always go by the name on your own inhaler and your prescriber's instructions.
How to use it — step by step
Getting the best from it
- If also prescribed as your reliever (Symbicort maintenance-and-reliever therapy), follow your written action plan for extra doses.1,2
- Slow inhalation; one puff per breath.
- A spacer improves delivery and reduces throat side-effects.
Looking after your inhaler
Wipe the mouthpiece weekly with a dry tissue; keep the cap on. Do not immerse the canister.
Most people lose some accuracy over time.3,4 We can check your inhaler technique at your appointment.
References & evidence base
- National Asthma Council Australia. Inhaler technique for people with asthma or COPD. Information paper for health professionals. Melbourne: National Asthma Council Australia, 2026.
- Australian Commission on Safety and Quality in Health Care. Inhaler technique — device-specific checklists. Sydney: ACSQHC, 2020.
Further reading
- Sanchis J, Gich I, Pedersen S; ADMIT Group. Systematic review of errors in inhaler use: has patient technique improved over time? Chest 2016;150(2):394–406.
- Usmani OS, Lavorini F, Marshall J, et al. Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respir Res 2018;19(1):10.
References are numbered in citation order (Vancouver/BMJ style) and were current at the time of writing. Always follow the leaflet for your specific device and your prescriber's instructions.
Everything starts with an assessment — your symptoms, breathing, exercise tolerance and daily function measured properly, so what follows is built on your lungs rather than an average.
Corrections: If something on this page is wrong, out of date or unclear, we want to know. Email reception@inspireclinic.au with the page name and what you believe is incorrect. Substantive corrections are made promptly, and the guide’s version and last-updated date are changed to reflect it.
